Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
International Journal of Cancer
|
January 8, 2015
Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau)
Marco Randazzo, Josef Beatrice, Andreas Huber, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2016
Synthesis of a selective HDAC6 inhibitor active in neuroblasts
Vincent Zwick, Claudia A Simões-Pires, Alessandra Nurisso, et al.
Chemmedchem
|
August 13, 2015
Discovery of Novel, Potent, and Specific Cell-Death Inducers in the Jurkat Acute Lymphoblastic Leukemia Cell Line
Emanuele Carosati, Natascha van den Höfel, Manuela Reif, et al.
Urology
|
July 10, 2012
Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners
Daniel Seiler, Marco Randazzo, Ulrich Leupold, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 7, 2017
Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations
Olivier Helfrich, Philippe Puech, Nacim Betrouni, et al.
World Journal of Urology
|
March 3, 2016
Clinical impact of prostate biopsy undergrading in an academic and community setting
Ashkan Mortezavi, Etienne Xavier Keller, Cédric Poyet, et al.
The Journal of Urology
|
January 16, 2016
Limitations of Elastography Based Prostate Biopsy
Jonas Schiffmann, Mircea Grindei, Zhe Tian, et al.
Oncotarget
|
April 21, 2017
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
Ashkan Mortezavi, Souzan Salemi, Niels J Rupp, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 22, 2016
5-Benzylidene-hydantoin is a new scaffold for SIRT inhibition: From virtual screening to activity assays
Lionel Sacconnay, Lucie Ryckewaert, Giuseppe Marco Randazzo, et al.
Cancer Medicine
|
June 12, 2020
Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study
Salome Adam, Eva Martin-Diener, Bertrand Camey, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
International Journal of Cancer
|
January 8, 2015
Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau)
Marco Randazzo, Josef Beatrice, Andreas Huber, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 22, 2016
Synthesis of a selective HDAC6 inhibitor active in neuroblasts
Vincent Zwick, Claudia A Simões-Pires, Alessandra Nurisso, et al.
Chemmedchem
|
August 13, 2015
Discovery of Novel, Potent, and Specific Cell-Death Inducers in the Jurkat Acute Lymphoblastic Leukemia Cell Line
Emanuele Carosati, Natascha van den Höfel, Manuela Reif, et al.
Urology
|
July 10, 2012
Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners
Daniel Seiler, Marco Randazzo, Ulrich Leupold, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
April 7, 2017
Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations
Olivier Helfrich, Philippe Puech, Nacim Betrouni, et al.
World Journal of Urology
|
March 3, 2016
Clinical impact of prostate biopsy undergrading in an academic and community setting
Ashkan Mortezavi, Etienne Xavier Keller, Cédric Poyet, et al.
The Journal of Urology
|
January 16, 2016
Limitations of Elastography Based Prostate Biopsy
Jonas Schiffmann, Mircea Grindei, Zhe Tian, et al.
Oncotarget
|
April 21, 2017
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
Ashkan Mortezavi, Souzan Salemi, Niels J Rupp, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
January 22, 2016
5-Benzylidene-hydantoin is a new scaffold for SIRT inhibition: From virtual screening to activity assays
Lionel Sacconnay, Lucie Ryckewaert, Giuseppe Marco Randazzo, et al.
Cancer Medicine
|
June 12, 2020
Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study
Salome Adam, Eva Martin-Diener, Bertrand Camey, et al.
Page
of 5